肥胖与乳腺癌不良风险及结局:机制见解与干预策略
本文综述肥胖与乳腺癌风险和结局的关系,涉及绝经前与绝经后及激素受体阳性与阴性人群。文章讨论肥胖通过炎症、血管生成和癌症干细胞促进肿瘤的分子机制,并汇总观察性研究显示体力活动与较低乳腺癌风险和更好结局相关,但需进一步前瞻性研究确定减重能否改善患者结局。
要点
- 肥胖与绝经后乳腺癌风险升高相关,并与所有年龄女性更差结局相关。
- 观察性研究显示体力活动增加与较低乳腺癌风险和更好结局相关。
核心结论
- 许多观察性研究表明运动结合减重与改善乳腺癌结局相关,但需进一步前瞻性研究确定减重能否改善患者结局。
- 希望正在进行的多项生活方式干预试验能支持将减重干预策略系统纳入乳腺癌患者照护。
研究设计与样本
- 综述,总结肥胖与乳腺癌发生和结局的关系、可能分子机制及生活方式干预研究。
主要发现
- 肥胖与绝经后女性乳腺癌风险升高相关,并与所有年龄女性更差疾病结局相关。
- 肥胖增加局部和循环促炎细胞因子、促进肿瘤血管生成并刺激最具恶性的癌症干细胞群体驱动癌症生长、侵袭和转移。
- 观察性研究显示体力活动增加与较低乳腺癌风险和更好结局相关。
- 近期生活方式干预可降低性类固醇、胰岛素/胰岛素样生长因子-1通路激活及与肥胖乳腺癌更差结局相关的炎症生物标志物。
临床怎么用
- 原文未据此给出推荐。
局限性
- 许多观察性研究提示运动结合减重与改善乳腺癌结局相关,但需进一步前瞻性研究确定减重能否改善患者结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Answer questions and earn CME/CNE Recent decades have seen an unprecedented rise in obesity, and the health impact thereof is increasingly evident. In 2014, worldwide, more than 1.9 billion adults were overweight (body mass index [BMI], 25-29.9 kg/m2 ), and of these, over 600 million were obese (BMI ≥30 kg/m2 ). Although the association between obesity and the risk of diabetes and coronary artery disease is widely known, the impact of obesity on cancer incidence, morbidity, and mortality is not fully appreciated. Obesity is associated both with a higher risk of developing breast cancer, particularly in postmenopausal women, and with worse disease outcome for women of all ages. The first part of this review summarizes the relationships between obesity and breast cancer development and outcomes in premenopausal and postmenopausal women and in those with hormone receptor-positive and -negative disease. The second part of this review addresses hypothesized molecular mechanistic insights that may underlie the effects of obesity to increase local and circulating proinflammatory cytokines, promote tumor angiogenesis and stimulate the most malignant cancer stem cell population to drive cancer growth, invasion, and metastasis. Finally, a review of observational studies demonstrates that increased physical activity is associated with lower breast cancer risk and better outcomes. The effects of recent lifestyle interventions to decrease sex steroids, insulin/insulin-like growth factor-1 pathway activation, and inflammatory biomarkers associated with worse breast cancer outcomes in obesity also are discussed. Although many observational studies indicate that exercise with weight loss is associated with improved breast cancer outcome, further prospective studies are needed to determine whether weight reduction will lead to improved patient outcomes. It is hoped that several ongoing lifestyle intervention trials, which are reviewed herein, will support the systematic incorporation of weight loss intervention strategies into care for patients with breast cancer. CA Cancer J Clin 2017;67:378-397. © 2017 American Cancer Society.
引用
- Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, et al. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017. PMID: 28763097. doi:10.3322/caac.21405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。